secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jasper Therapeutics, Inc. (JSPR)
CIK:        0001788028
Form:       8-K
Filed at:   2026-05-21T20:01:33+00:00
Accession:  0001213900-26-060029
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jasper Therapeutics director Christian Nolet resigns; Svetlana Lucas joins audit committee
--------------------------------------------------------------------------------

- Christian Nolet resigned from Board and all committees effective May 15, 2026.
- Resignation not due to any disagreement with the company's operations, policies or practices.
- Board appointed Svetlana Lucas, Ph.D. to the Audit Committee.
- No other changes to board composition or officer roles disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/0001213900-26-060029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/ea0291168-8k_jasper.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-060029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer